Functional Brain MRI to Understand Pain Phenotypes in Knee Osteoarthritis
INDIGO
2 other identifiers
interventional
60
1 country
3
Brief Summary
Some people with knee osteoarthritis (gonarthrosis) experience pain differently. In some, the pain is described as "nociceptive" (directly related to the joint), while in others it has "neuropathic" characteristics (related to nerve function). The goal of this multicenter, cross-sectional and comparative study is to compare resting brain activity in a brain region called the anterior insula among female patients with painful knee osteoarthritis who experience nociceptive pain compared to those with neuropathic pain. Researchers will compare brain activity at rest between these two types of pain in women over 40 with painful knee osteoarthritis. A better understanding could help improve pain management in the future. Participants will be asked to :
- complete questionnaires during the inclusion visit and on the day of the scan,
- undergo a clinical examination and a blood test at the inclusion visit,
- undergo a functional MRI (fMRI), an imaging test that allows observation of brain activity at rest. Paticipants in the study does not involve any additional treatment. the fMRI scan is non-invasive and does not require any injections.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Jul 2026
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 24, 2026
CompletedFirst Posted
Study publicly available on registry
June 25, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2028
June 25, 2026
April 1, 2026
2.1 years
April 24, 2026
June 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Resting-state anterior insula activity measured by functional MRI (BOLD signal amplitude)
Comparison of resting-state anterior insula brain activity between patients with painful knee osteoarthritis with nociceptive pain and those with neuropathic-like pain, classified using the painDETECT questionnaire.
At Visit 2 : within 30 days after inclusion, following Visit 1
Secondary Outcomes (3)
Functional connectivity of the anterior insula with pain-related brain regions (resting-state MRI)
At Visit 2 : within 30 days after inclusion
Correlation between clinical pain scores ans anterior insula activity (resting-state fMRI)
Clinical measures at Visit 1 and imaging measures at Visit 2 (within 30 days after inclusion)
Correlation between clinical pain scores ans anterior insula functional connectivity (resting-state fMRI)
Clinical measures at visit 1 ; imaging at visit 2 (within 30 days after inclusion)
Other Outcomes (1)
Patient clusters identified using multimodal analysis including functional MRI and clinical data
Data collected at Visit 1 and Visit 2 (within 30 days after inclusion)
Study Arms (2)
Nociceptive pain knee osteroarthritis
OTHERParticipants with painful knee osteoarthritis classified as having nociceptive pain based on PainDETECT questionnaire score ≤12.
Neuropathic-like pain knee osteoarthritis
OTHERParticipants with painful knee osteoarthritis classified as having neuropathic-like pain based on PainDETECT questionnaire score \>13.
Interventions
Blood sampling will be performed at the inclusion visit. A biological assessment will include high sensitivity C reactive protein (hs-CRP) and metabolic markers (lipid profile, HbA1c, and fasting glucose). Additional blood samples (4 tubes) will be collected for biobank, including plasma and serum storage for the measurement of inflammatory markers.
Resting-state functional brain MRI will be performed at Visit 2 (within 30 days of the screening visit). Participants will undergo a brain MRI acquisition at rest to evaluate anterior insula activity and functional connectivity with pain-related brain regions.
Eligibility Criteria
You may qualify if:
- Women aged 40 or older (only women will be included to ensure consistency in the analyses, given the higher prevalence of osteoarthritis in women and the influence of sex/gender on the experience of pain)
- Diagnosis of femorotibial osteoarthritis of the knee according to the 1986 American College of Rheumatology criteria
- Presence of knee pain with an intensity of ≥ 4/10 on a numerical rating scale (NRS)
- Chronic knee pain, i.e., lasting at least 6 months with at least 15 days of pain in the past 30 days
- Completion of the PainDETECT questionnaire, which will allow the patient to be assigned to one of two groups prior to the enrollment visit (those with nociceptive pain \[score ≤ 12\] and those with neuropathic pain \[score \> 13\])
- Patients have read and understood the information letter
- Patients have signed the informed consent form
- Patients are enrolled in a social security program
You may not qualify if:
- Other joint diseases affecting the knees (gout, chondrocalcinosis, rheumatoid arthritis, spondyloarthritis, psoriatic arthritis)
- Conditions that, in the investigator's opinion, interfere with the assessment of osteoarthritic pain, such as conditions causing neuropathic pain in the lower extremities (e.g., peripheral neuropathy, chronic radiculopathy) or fibromyalgia
- Kellgren-Lawrence radiographic stage IV in one or both knees
- Patients with one or more knee prostheses
- Claustrophobia making MRI impossible
- Contraindication to MRI
- Pregnant or breastfeeding women
- Patients under guardianship, conservatorship, deprived of liberty, or under judicial protection
- Patients who have participated in an interventional clinical trial within the last 6 months that could impact the primary endpoint
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
CHU Clermont-Ferrand
Clermont-Ferrand, France
APHP - Pitié-Salpêtrière
Paris, France
APHP - Saint-Antoine
Paris, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sylvain MATHIEU
University Hospital, Clermont-Ferrand
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2026
First Posted
June 25, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
August 1, 2028
Study Completion (Estimated)
August 1, 2028
Last Updated
June 25, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share